Five-year results from the PARTNER 3 trial, which evaluated the balloon-expandable SAPIEN 3® TAVI versus surgical aortic valve replacement (SAVR) in low-risk patients.
A position paper by the European Society of Heart Failure, the Association of Acute Cardiovascular Care, and the European Association for Percutaneous Cardiovascular Interventions addresses the challenges in managing acute heart failure (AHF) with associated valvular heart disease (VHD).
This meta-analysis, encompassing 6 clinical trials, compares percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in cases of left main coronary artery disease or multivessel disease, presenting results stratified according to the SYNTAX score.
If you wish to receive our monthly newsletter, containing all the news collected on our portal, please fill in your email address and click on the “Subscribe” button.